Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126884271 | 12688427 | 1 | I | 20160818 | 20160826 | 20160826 | EXP | IT-MINISAL02-371625 | IT-TEVA-687571ACC | TEVA | RAPOSIO E,BERTOZZI N,QUARTA L,GRIGNAFFINI E. 41-43. | 49.00 | YR | F | Y | 0.00000 | 20160826 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126884271 | 12688427 | 1 | SS | QUETIAPINE FUMARATE. | QUETIAPINE FUMARATE | 1 | U | U | 0 | ||||||||||
| 126884271 | 12688427 | 2 | PS | FENTANYL. | FENTANYL | 1 | Unknown | U | U | 20747 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126884271 | 12688427 | 1 | Product used for unknown indication |
| 126884271 | 12688427 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126884271 | 12688427 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126884271 | 12688427 | Neuroleptic malignant syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |